IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.

IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.

<h4>Background</h4>The clinical utility of testing for antiphospholipid antibodies (aPL) of IgA isotype remains controversial.<h4>Methodology/principal findings</h4>To address this issue, we reasoned that if IgA aPL contribute to the clinical manifestations of the antiphospho...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nadera J Sweiss, Ronghai Bo, Reena Kapadia, Deborah Manst, Farzan Mahmood, Tara Adhikari, Suncica Volkov, Maria Badaracco, Mary Smaron, Anthony Chang, Joseph Baron, Jerrold S Levine
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2010
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/bcd6a91bee5d4518a6fbce993519e1b8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Documents similaires